Could a new pill break up Alzheimer's brain clumps?

NCT ID NCT06182085

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests a new drug called PRI-002 in 304 people with mild memory problems or early Alzheimer's. The drug aims to break apart harmful protein clumps in the brain that are linked to Alzheimer's. Researchers want to see if it is safe and can slow down memory and thinking decline over 48 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE, EARLY ONSET are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • A-Shine, s.r.o.

    Pilsen, 30100, Czechia

  • AOU Policlinico Umberto I

    Rome, 00161, Italy

  • ASST Spedali Civili di Brescia

    Brescia, 25123, Italy

  • Brain Research Center Amsterdam B.V.

    Amsterdam, 1081 GN, Netherlands

  • Brain Research Center Den Bosch B.V.

    's-Hertogenbosch, 5223 LA, Netherlands

  • Brain Research Center Zwolle B.V.

    Zwolle, 8025 AZ, Netherlands

  • CLINTRIAL, s.r.o.

    Prague, 10000, Czechia

  • Charité - Universitätsmedizin

    Berlin, 13125, Germany

  • Clinica Neurologica Dipartimento di Neuroscienze e Imaging (CAST)

    Chieti, 66013, Italy

  • Euromedis Sp. z o.o., Centrum Medyczne EUROMEDIS

    Szczecin, 70-111, Poland

  • FORBELI s.r.o.

    Prague, 14800, Czechia

  • Fondazione IRCCS.Istituto Neurologico Carlo Besta

    Milan, 20133, Italy

  • Fondazione Policlinico Universitario A. Gemelli IRCCS

    Rome, 00168, Italy

  • Fundació ACE - Institut Català de Neurociències Aplicades

    Barcelona, 08028, Spain

  • Hospital Clínico Universitario Virgen de la Arrixaca

    El Palmar, Murcia, 30120, Spain

  • Hospital Universitario Doctor Peset

    Valencia, 46017, Spain

  • Hospital Universitario Virgen Macarena,

    Seville, 41003, Spain

  • Hospital Viamed Montecanal

    Zaragoza, 50012, Spain

  • INEP Medical s.r.o.

    Prague, 18600, Czechia

  • IRCCS Ospedale San Raffaele

    Milan, 20132, Italy

  • ISPG - Institut für Studien zur Psychischen Gesundheit

    Mannheim, 68165, Germany

  • Krakowska Akademia Neurologii Sp. z o.o., Centrum Neurologii Klinicznej

    Krakow, 30-505, Poland

  • Neuro Health Centrum ltd.

    Brno, 62800, Czechia

  • NeuroCor, ul. Medweciego 7/U12

    Krakow, 31-870, Poland

  • Neuroprotect Sp. z o.o., Centrum Medyczne NeuroProtect

    Warsaw, 01-684, Poland

  • Neuropsychiatrie s.r.o.

    Prague, 16000, Czechia

  • NeuropsychiatrieHK, s.r.o.

    Hradec Králové, 50341, Czechia

  • Ospedale Bellaria - IRCCS Istituto delle Scienze Neurologiche

    Bologna, 40139, Italy

  • Ospedale Santa Maria della Misericordia

    Perugia, 06129, Italy

  • Revit Sp. z o.o., Podlaskie Centrum Psychogeriatrii

    Bialystok, 15-756, Poland

  • Technische Universität München

    München, 81675, Germany

  • Uniklinik RWTH Aachen

    Aachen, 52074, Germany

  • University Medical Center Rostock

    Rostock, 18147, Germany

  • Universitätsklinikum Düsseldorf

    Düsseldorf, 40225, Germany

  • Universitätsklinikum Magdeburg

    Magdeburg, 39120, Germany

  • Universitätsklinikum Münster - Klinik für Allgemeine Neurologie

    Münster, 48149, Germany

  • Universitätsklinikum Ulm

    Ulm, 89081, Germany

  • Wielospecjalistyczne Centrum Medyczne "Ibismed" s.c.

    Zabrze, 41-800, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.